vs
康耐视(CGNX)与FOCUS UNIVERSAL INC.(FCUV)财务数据对比。点击上方公司名可切换其他公司
康耐视的季度营收约是FOCUS UNIVERSAL INC.的336899.9倍($252.3M vs $749)。康耐视同比增速更快(9.9% vs -99.4%)。康耐视自由现金流更多($72.3M vs $-1.4M)。过去两年康耐视的营收复合增速更高(9.4% vs -93.5%)
康耐视(Cognex Corporation)是总部位于美国马萨诸塞州内蒂克的机器视觉系统、软件及传感器制造商,业务覆盖全球20余个国家和地区,为各工业领域客户提供高性能的视觉相关产品及解决方案。
环球健康服务公司(UHS)是一家总部位于宾夕法尼亚州普鲁士王市的美国财富500强企业,主营医院运营与医疗保健服务。根据该公司2024年公布的数据,其全年总营收达到158亿美元,是美国医疗领域颇具规模的领军企业之一。
CGNX vs FCUV — 直观对比
营收规模更大
CGNX
是对方的336899.9倍
$749
营收增速更快
CGNX
高出109.3%
-99.4%
自由现金流更多
CGNX
多$73.7M
$-1.4M
两年增速更快
CGNX
近两年复合增速
-93.5%
损益表 — Q4 2025 vs Q4 2025
| 指标 | ||
|---|---|---|
| 营收 | $252.3M | $749 |
| 净利润 | $32.7M | — |
| 毛利率 | 65.7% | -6912.1% |
| 营业利润率 | 14.0% | -119973.6% |
| 净利率 | 12.9% | — |
| 营收同比 | 9.9% | -99.4% |
| 净利润同比 | 15.2% | — |
| 每股收益(稀释后) | $0.20 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CGNX
FCUV
| Q4 25 | $252.3M | $749 | ||
| Q3 25 | $276.9M | $28.7K | ||
| Q2 25 | $249.1M | $35.3K | ||
| Q1 25 | $216.0M | $190.3K | ||
| Q4 24 | $229.7M | $133.2K | ||
| Q3 24 | $234.7M | $74.2K | ||
| Q2 24 | $239.3M | $11.2K | ||
| Q1 24 | $210.8M | $179.5K |
净利润
CGNX
FCUV
| Q4 25 | $32.7M | — | ||
| Q3 25 | $17.7M | $-1.2M | ||
| Q2 25 | $40.5M | $-1.5M | ||
| Q1 25 | $23.6M | $-1.3M | ||
| Q4 24 | $28.3M | — | ||
| Q3 24 | $29.6M | $1.4M | ||
| Q2 24 | $36.2M | $-1.4M | ||
| Q1 24 | $12.0M | $-1.3M |
毛利率
CGNX
FCUV
| Q4 25 | 65.7% | -6912.1% | ||
| Q3 25 | 67.6% | -5.6% | ||
| Q2 25 | 67.4% | -35.1% | ||
| Q1 25 | 66.8% | 16.1% | ||
| Q4 24 | 68.7% | -95.4% | ||
| Q3 24 | 67.9% | 42.7% | ||
| Q2 24 | 69.6% | — | ||
| Q1 24 | 67.3% | 50.3% |
营业利润率
CGNX
FCUV
| Q4 25 | 14.0% | -119973.6% | ||
| Q3 25 | 20.9% | -4114.4% | ||
| Q2 25 | 17.4% | -4366.7% | ||
| Q1 25 | 12.1% | -668.3% | ||
| Q4 24 | 13.4% | -1507.4% | ||
| Q3 24 | 13.4% | -2353.8% | ||
| Q2 24 | 16.1% | -10965.3% | ||
| Q1 24 | 6.7% | -676.3% |
净利率
CGNX
FCUV
| Q4 25 | 12.9% | — | ||
| Q3 25 | 6.4% | -4065.6% | ||
| Q2 25 | 16.3% | -4261.7% | ||
| Q1 25 | 10.9% | -657.7% | ||
| Q4 24 | 12.3% | — | ||
| Q3 24 | 12.6% | 1942.9% | ||
| Q2 24 | 15.1% | -12151.6% | ||
| Q1 24 | 5.7% | -732.9% |
每股收益(稀释后)
CGNX
FCUV
| Q4 25 | $0.20 | — | ||
| Q3 25 | $0.10 | — | ||
| Q2 25 | $0.24 | — | ||
| Q1 25 | $0.14 | $-0.17 | ||
| Q4 24 | $0.17 | $-4.57 | ||
| Q3 24 | $0.17 | $0.02 | ||
| Q2 24 | $0.21 | $-0.02 | ||
| Q1 24 | $0.07 | $-0.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $262.9M | $8.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.5B | $2.6M |
| 总资产 | $2.0B | $8.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
CGNX
FCUV
| Q4 25 | $262.9M | $8.0M | ||
| Q3 25 | $245.9M | $454.4K | ||
| Q2 25 | $179.3M | $1.2M | ||
| Q1 25 | $143.7M | $2.2M | ||
| Q4 24 | $186.1M | $3.6M | ||
| Q3 24 | $197.1M | $5.4M | ||
| Q2 24 | $176.6M | $40.6K | ||
| Q1 24 | $138.9M | $114.1K |
股东权益
CGNX
FCUV
| Q4 25 | $1.5B | $2.6M | ||
| Q3 25 | $1.5B | $174.8K | ||
| Q2 25 | $1.5B | $845.6K | ||
| Q1 25 | $1.4B | $1.9M | ||
| Q4 24 | $1.5B | $3.2M | ||
| Q3 24 | $1.6B | $5.4M | ||
| Q2 24 | $1.5B | $1.2M | ||
| Q1 24 | $1.5B | $2.4M |
总资产
CGNX
FCUV
| Q4 25 | $2.0B | $8.9M | ||
| Q3 25 | $2.0B | $880.4K | ||
| Q2 25 | $2.0B | $1.7M | ||
| Q1 25 | $1.9B | $2.7M | ||
| Q4 24 | $2.0B | $4.1M | ||
| Q3 24 | $2.1B | $6.2M | ||
| Q2 24 | $2.0B | $4.9M | ||
| Q1 24 | $2.0B | $5.0M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $74.9M | $-1.4M |
| 自由现金流经营现金流 - 资本支出 | $72.3M | $-1.4M |
| 自由现金流率自由现金流/营收 | 28.7% | -186175.6% |
| 资本支出强度资本支出/营收 | 1.0% | 105.2% |
| 现金转化率经营现金流/净利润 | 2.29× | — |
| 过去12个月自由现金流最近4个季度 | $236.8M | $-5.1M |
8季度趋势,按日历期对齐
经营现金流
CGNX
FCUV
| Q4 25 | $74.9M | $-1.4M | ||
| Q3 25 | $87.5M | $-1.1M | ||
| Q2 25 | $42.6M | $-1.4M | ||
| Q1 25 | $40.5M | $-1.2M | ||
| Q4 24 | $51.4M | $-997.9K | ||
| Q3 24 | $56.3M | $-1.9M | ||
| Q2 24 | $27.8M | $-829.9K | ||
| Q1 24 | $13.6M | $-892.1K |
自由现金流
CGNX
FCUV
| Q4 25 | $72.3M | $-1.4M | ||
| Q3 25 | $86.0M | $-1.1M | ||
| Q2 25 | $40.4M | $-1.4M | ||
| Q1 25 | $38.0M | $-1.2M | ||
| Q4 24 | $49.3M | $-1.0M | ||
| Q3 24 | $51.9M | $-1.9M | ||
| Q2 24 | $23.3M | $-834.6K | ||
| Q1 24 | $9.6M | $-897.1K |
自由现金流率
CGNX
FCUV
| Q4 25 | 28.7% | -186175.6% | ||
| Q3 25 | 31.1% | -3705.4% | ||
| Q2 25 | 16.2% | -4047.4% | ||
| Q1 25 | 17.6% | -653.6% | ||
| Q4 24 | 21.5% | -753.3% | ||
| Q3 24 | 22.1% | -2614.6% | ||
| Q2 24 | 9.7% | -7428.8% | ||
| Q1 24 | 4.5% | -499.8% |
资本支出强度
CGNX
FCUV
| Q4 25 | 1.0% | 105.2% | ||
| Q3 25 | 0.5% | 7.8% | ||
| Q2 25 | 0.9% | 4.8% | ||
| Q1 25 | 1.2% | 12.3% | ||
| Q4 24 | 0.9% | 4.1% | ||
| Q3 24 | 1.9% | 4.7% | ||
| Q2 24 | 1.9% | 41.8% | ||
| Q1 24 | 1.9% | 2.8% |
现金转化率
CGNX
FCUV
| Q4 25 | 2.29× | — | ||
| Q3 25 | 4.95× | — | ||
| Q2 25 | 1.05× | — | ||
| Q1 25 | 1.72× | — | ||
| Q4 24 | 1.81× | — | ||
| Q3 24 | 1.90× | -1.34× | ||
| Q2 24 | 0.77× | — | ||
| Q1 24 | 1.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图